President & CEO
Sue Washer, President and CEO of AGTC for 14 years, has led the company in efficiently completing critical milestones including five INDs and three early stage clinical trials, negotiated numerous licensing deals with academic, governmental and commercial entities, and recruited an experienced and highly effective management team. Sue led the Company’s successful IPO and secondary financing and raised over $90M from public market investors and most recently led the negotiations with Biogen resulting in a wide ranging partnership deal with a $124M upfront payment. Sue gained pharmaceutical management and research experience during 9 years at Abbott Labs and Eli Lilly. Sue earned her undergraduate degree in biochemistry from Michigan State University and an MBA from the University of Florida.